Status:
COMPLETED
Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists
Lead Sponsor:
Universidad Católica San Antonio de Murcia
Conditions:
Beta Alanine Supplementation
Eligibility:
MALE
18-60 years
Phase:
NA
Brief Summary
Randomized, controlled, double-blind, single-center, double-blind clinical trial with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product)...
Detailed Description
Subjects meeting the selection criteria will be randomly assigned to each of the study groups (investigational product dose 1 or dose 2, or placebo, depending on the group to which they have been assi...
Eligibility Criteria
Inclusion
- Male cyclists with more than two years of cycling experience.
- Perform tests without fatigue.
- Road bike training at least twice a week.
Exclusion
- Participants with chronic illness.
- Have a long-term injury that prevents you from training in the previous month.
- Inability to understand informed consent.
- Have consumed beta alanine in the three years prior to the start of the study.
- Consumption of other supplements that may alter performance.
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06180512
Start Date
December 4 2023
End Date
January 22 2024
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Murcia
Murcia, Spain, 30107